Examkin

Soru

Zorluk: Çok zorClinical Preventive Services and Screening

An establishment of care visit is scheduled for a 38-year-old female patient with a history of severe rheumatoid arthritis. Her joint disease is currently well controlled on a regimen of methotrexate and etanercept. She reports feeling well with no acute symptoms. Her family history is significant for colorectal cancer in her father, who was diagnosed at age 46. Social history reveals she is a former smoker, having quit 5 years ago after accumulating a 10 pack-year history. Her gynecological records indicate her most recent cervical cytology and high-risk human papillomavirus (hrHPV) co-testing was performed 4 years ago with negative results. Her immunization log reveals a Tdap vaccination 12 years ago. Recent serology confirms she is negative for varicella IgG antibodies, and she has no clinical history of chickenpox. During the consultation, she expresses concern about undiagnosed malignancies and asks whether a serum tumor marker test would be appropriate to screen for ovarian cancer. Physical examination and vital signs today are unremarkable. Which of the following sets of preventive and screening measures is most indicated for this patient at this time?

  1. Colonoscopy, cervical cytology, and Tdap vaccineCevap
  2. B
    Colonoscopy, cervical cytology, Tdap vaccine, and varicella vaccine
  3. C
    Colonoscopy and Tdap vaccine only
  4. D
    Cervical cytology and Tdap vaccine only
  5. E
    Colonoscopy, cervical cytology, Tdap vaccine, and serum CA-125 level

Cevap

The most appropriate management is to perform a colonoscopy, perform cervical cytology, and administer the Tdap vaccine.
The correct answer accurately synthesizes three distinct guideline modifications for this specific patient. First, she requires a colonoscopy now because patients with a first-degree relative diagnosed with colorectal cancer before age 60 must begin screening at age 40 or 10 years before the relative's age at diagnosis (in her case, 46−10=3646 - 10 = 36 years of age). Second, she requires cervical cytology because she is immunocompromised (taking etanercept and methotrexate); the ASCCP guidelines state immunocompromised women should undergo co-testing every 3 years (not 5 years) or annual cytology, meaning she is overdue since her last test was 4 years ago. Third, she is due for a Tdap booster, which is required every 10 years.

Adım Adım Çözüm

1
Analyze the patient's risk factors for colorectal cancer to determine the screening timeline.
The patient's father was diagnosed with colon cancer at age 46. Guidelines require screening to begin at age 40 or 10 years prior to the relative's diagnosis, whichever comes first.
Calculating 46−10=3646 - 10 = 36 establishes that she should have begun screening at age 36. Since she is currently 38, she is overdue for a colonoscopy.
2
Evaluate the patient's cervical cancer screening requirements based on her comorbidities.
She is immunocompromised due to etanercept and methotrexate therapy. Immunocompromised women require cervical co-testing every 3 years (or annual cytology).
Her last co-test was 4 years ago, making her overdue for cervical screening. The average-risk 5-year interval does not apply here.
3
Assess immunization needs taking into account her medication profile.
She requires a Tdap booster (last received 12 years ago). However, despite being non-immune to varicella, she cannot receive the varicella vaccine.
Etanercept (a TNF-alpha inhibitor) causes profound immunosuppression, making all live-attenuated vaccines (like varicella and MMR) strictly contraindicated due to the risk of disseminated infection.
4
Evaluate the request for ovarian cancer screening.
The USPSTF recommends against routine screening for ovarian cancer (Grade D) in asymptomatic women without a known genetic syndrome.
The low disease prevalence results in a very low positive predictive value (PPV) for tests like CA-125, leading to false positives and unnecessary surgeries.

Anahtar Kavram

Preventive medicine in immunocompromised patients requires modified screening intervals (e.g., more frequent cervical screening, accelerated colonoscopy for family history) and strict avoidance of live-attenuated vaccines.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Clinical Preventive Services and Screening

Bu konudan daha fazla soru